SILO Pharma Inc (NASDAQ:SILO) has a beta value of 1.86 and has seen 3.16 million shares traded in the recent trading session. The company, currently valued at $3.71M, closed the recent trade at $0.83 per share which meant it lost -$0.27 on the day or -24.67% during that session. The SILO stock price is -442.17% off its 52-week high price of $4.50 and 14.46% above the 52-week low of $0.71.

SILO Pharma Inc (NASDAQ:SILO) trade information

Sporting -24.67% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SILO stock price touched $0.83 or saw a rise of 26.54%. Year-to-date, SILO Pharma Inc shares have moved -6.89%, while the 5-day performance has seen it change 2.30%. Over the past 30 days, the shares of SILO Pharma Inc (NASDAQ:SILO) have changed -20.32%.

SILO Pharma Inc (SILO) estimates and forecasts

The company’s shares have lost -35.26% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 11.18% over the past 5 years.

SILO Dividends

SILO Pharma Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Apr 30, 2025 , the former fund manager holds about 0.17% shares in the company for having 164.24 shares of worth $0.13 million while later fund manager owns 25.8 shares of worth $20902.0 as of Mar 31, 2025 , which makes it owner of about 0.03% of company’s outstanding stock.